<DOC>
	<DOCNO>NCT01381627</DOCNO>
	<brief_summary>Lung cancer second commonly diagnose primary neoplasia Canada account 22 865 new case 2007 . Recent randomized trial show significantly well diagnostic yield few unnecessary thoracotomy endobronchial ultrasound-guided transbronchial needle aspiration ( EBUS-TBNA ) compare conventional TBNA various clinical condition include peripheral pulmonary lesion sarcoidosis . EBUS-TBNA routinely perform institution stag pulmonary mediastinal cancer . EBUS-TBNA perform monitored anesthesia care ( MAC ) endoscopy suite Centre de soins ambulatoires Hôpital Maisonneuve-Rosemont . Remifentanil , use combined regime single agent prove effective safe MAC . Nonetheless , anesthesiologist still confront respiratory depression profile remifentanil commonly use agent . An analysis ASA Closed Claims demonstrate respiratory depression remain significant drawback MAC remote location . Furthermore , patient coexist pulmonary disease schedule EBUS-TBNA increase risk complication . The investigator hypothesize compare use remifentanil-based MAC protocol , use dexmedetomidine-based MAC protocol EBUS-TBNA result low incidence major respiratory hemodynamic adverse event ( bradypnea , apnea , oxygen desaturation , hypotension , hypertension , bradycardia tachycardia ) equivalent overall procedure condition .</brief_summary>
	<brief_title>Safety Evaluation Dexmedetomidine EBUS-TBNA</brief_title>
	<detailed_description>See</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Subjects plan EBUSTBNA conscious sedation . Age 1875 year old . American Society Anesthesiologists class IIII . The subject able understand study objective , experimental protocol procedure , capable providing inform consent . Subjects allergic study drug . BMI &gt; 34 kg/m2 . Severe renal hepatic failure . Pregnancy . Emergent procedure . Heart failure NYHA &gt; III . Systolic blood pressure &lt; 90 mmHg . Advanced heart block ( unless patient pacemaker ) . Unstable angina and/or myocardial infarction within past 6 week . FEV1 ≤ 0.8 L. Oxygendependent patient . Use α2adrenoreceptor agonist antagonist within 14 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>EBUS-TBNA</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Precedex</keyword>
	<keyword>Remifentanil</keyword>
	<keyword>Ultiva</keyword>
	<keyword>Monitored Anesthesia Care</keyword>
	<keyword>Sedation</keyword>
	<keyword>Bronchoscopy</keyword>
	<keyword>Lung cancer</keyword>
	<keyword>Mediastinal node</keyword>
	<keyword>Cancer stag</keyword>
	<keyword>Anesthesia</keyword>
	<keyword>Remote location</keyword>
</DOC>